Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1
about
P1343
Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.Cross-reactivity between HLA-A2-restricted FLU-M1:58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individualsMechanisms of HIV protein degradation into epitopes: implications for vaccine designHigh avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral functionComprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the ImmunopeptidomePD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progressionThe contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes.Contribution of mass spectrometry to contemporary immunology.An endogenous HIV envelope-derived peptide without the terminal NH3+ group anchor is physiologically presented by major histocompatibility complex class I molecules.A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcriptionHIV's evasion of the cellular immune response.Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiencyDifferential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection.Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons.Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA allelesInduction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjectsFunctional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection.Programmed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load.Impact of MHC class I diversity on immune control of immunodeficiency virus replication.Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.Herman N. Eisen: Mentor to manySuperior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.The functional CD8 T cell response to HIV becomes type-specific in progressive disease.Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clustersSchistosoma mansoni soluble egg antigens enhance T cell responses to a newly identified HIV-1 Gag H-2b epitopeQuantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response.Differential proteasomal processing of hydrophobic and hydrophilic protein regions: contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef.Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors.Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity.Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression.
P2860
Q24523051-39B25BE7-C124-4B6D-8DDA-C26E91A5F9AAQ24802424-5E57329F-8941-446D-8EC9-5A47093D2823Q26866505-DF8AED6D-A11D-49D8-A5FA-946654721A73Q27323727-278E6D30-9806-4A68-BD2F-750E98F710BBQ28548093-815EBB7C-955F-43A4-963F-106E0C150630Q29618956-E05DFBEA-8FD3-4793-B80E-BF9142D40681Q30444065-C84D6EE1-5C5B-4CCD-ACA5-A5CB37C077C8Q30448060-C420A9FC-12B1-45BD-95A3-5E91E9A2A6D2Q30697033-C1F4A86E-6631-4E0B-A49D-43B48B668EA3Q31019004-E090A15D-D42C-4E40-9598-A0C088CE5AADQ33603919-EC994FE6-5464-4AC4-8DA3-E5B14D83987AQ33615194-F218636F-6DCB-48D2-B165-E5EE266DED82Q33683334-78FFC493-5E77-41A6-8F27-63F07316D5DFQ33782574-B6B63785-C311-49B5-9F56-06AAA5B5C13DQ33803446-0E0DD9B0-65BF-49B6-AC40-7308CADDD4CCQ33805975-089FAC9E-D250-4ACD-A0A7-C9EB386F2FB6Q33809451-D6A34A39-7304-432C-BFD7-1660AE6BCEB3Q33817504-5C12DA57-94BF-427A-9894-07301FBAA7DEQ33835126-00110026-2863-4DF7-ABCE-9426EC0427CFQ33842771-E5901283-E1B7-41DC-81B2-D14E51A02894Q33943869-481DF829-B671-45CB-977A-8EAEE3BED0F3Q33998262-C5B95526-AA4E-48CB-BC2E-4EA2E20410F3Q34120821-791DA118-ED32-4164-A52F-70B465A85716Q34197037-1C357D7E-C180-40B2-984C-1669BC1D40BAQ34235198-7502316B-4CDD-4E64-A9C7-CA72223B2554Q34348731-6E6F4014-D478-470C-918C-F19988A0526EQ34459495-22543842-E8AC-42D9-919D-2E63423AC854Q34692601-F2C37B4B-DAA1-4056-822E-0919DF93DFD7Q34758044-C75F6091-A09D-44A3-98F0-4D79CC73BAA9Q34815358-4B697F70-25F7-43FE-B198-FB29DD7D649BQ34998234-17BCF02E-6C89-4E9F-A24E-07F798110DA6Q35021109-F67D534B-74C0-48F1-A697-A36402F79653Q35130764-07E65800-2E38-40E2-9289-305EC9FC71B9Q35146742-D88EB32A-87C6-45F3-B2CD-A4F5B9C55A32Q35232992-0661AC24-5E50-4C18-A7CF-A0B2FFFFBDB9Q35542741-2AA49504-3D85-47A3-8789-D69B15273EC2Q35867686-59022D0E-6CEC-400A-9FF5-6EF5041782C8Q35869488-8FD84EDA-E27B-4569-A35E-5739B43BBF98Q35898707-4555718A-7DEC-4CFB-9A30-AD90F905D496Q35904453-AC94066D-8569-4F16-B2F2-850F1731CE7B
P2860
Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Naturally processed viral pept ...... immunodeficiency virus type 1
@ast
Naturally processed viral pept ...... immunodeficiency virus type 1
@en
type
label
Naturally processed viral pept ...... immunodeficiency virus type 1
@ast
Naturally processed viral pept ...... immunodeficiency virus type 1
@en
prefLabel
Naturally processed viral pept ...... immunodeficiency virus type 1
@ast
Naturally processed viral pept ...... immunodeficiency virus type 1
@en
P2093
P2860
P921
P356
P1476
Naturally processed viral pept ...... immunodeficiency virus type 1
@en
P2093
A Aldovini
B D Walker
R P Johnson
T J Tsomides
P2860
P304
P356
10.1084/JEM.180.4.1283
P407
P4510
P577
1994-10-01T00:00:00Z